Nicotinamide derivatives and their use as therapeutic agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/496 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) A61P 43/00 (2006.01) C07D 401/00 (2006.01)

Patent

CA 2573198

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where m, n, p, V, R1, R2, R3, R4, R5 and R6 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.

Il est exposé des procédés de traitement d'une maladie ou affection médiée par la SCD (Stéaroyl Coenzyme A désaturase) chez un mammifère, de préférence chez un humain, lesquels procédés comprennent d'administrer à un mammifère qui en a besoin un composé de formule (I) : où m, n, p, V, R1, R2, R3, R4, R5 et R6 sont définis ici. Il est également exposé des compositions pharmaceutiques comprenant les composés de formule (I).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nicotinamide derivatives and their use as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nicotinamide derivatives and their use as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinamide derivatives and their use as therapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1847475

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.